TrueScale Capital

TrueScale Capital was an India-based venture capital and growth equity firm focused on Series B and Series C investments rather than a drug-development or healthcare operating company. The firm invested primarily in consumer and enterprise technology businesses, with at least one disclosed medtech investment in Axio Biosolutions. Public profiles indicate it was founded in 2020 and headquartered in Mumbai, with an additional presence in Bengaluru. In January 2023, TrueScale entered a transaction with IIFL Asset Management, under which its managed funds and sponsorship were transferred or combined with IIFL AMC; multiple databases subsequently marked the firm as acquired or inactive. As a result, TrueScale should be treated as a financial investor, not a biotech/pharma/healthcare company.